DOR Appoints Cyrille F. Buhrman to Its Board of Directors (Market Wire via Yahoo! Finance)
DOR BioPharma, Inc., a biopharmaceutical company addressing life-threatening side effects of cancer and cancer treatments, serious gastrointestinal diseases and disorders, and biodefense countermeasures, today announced the appointment of Cyrille F.

Advancis Pharmaceutical Reports on Meeting With FDA Reviewing Keflex PULSYS Phase III Trial Design (RedNova)
GERMANTOWN, Md., June 26 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced it has concluded a Pre-Phase III meeting with the U.S.

Taxotere(R) (docetaxel) Granted FDA Priority Review for Treatment of Locally Advanced Squamous Cell Carcinoma of the ... (PR Newswire via Yahoo! Finance)
Sanofi-aventis announced today that the U.S. Food and Drug Administration has accepted for filing and assigned priority review status to the supplemental new drug application for Taxotere Injection Concentrate in combination with cisplatin and fluorouracil for the induction therapy of patients with locally advanced squamous cell carcinoma of the head and neck prior to chemoradiotherapy and ...